This Viewpoint examines network meta-analyses that explore the efficacy of various antipsychotics in treating schizophrenia.
This Viewpoint discusses the brain basis for irritability across the life span in the context of the extensive burden on individuals, their families, and the public at large.
This Viewpoint examines the role of private equity in behavioral health care in the United States.
This phase 2 randomized clinical trial investigates the effect of treatment with cognitive behavioral therapy, administered with antidepressant medication, on recurrence prevention when medication treatment is maintained or withdrawn after recovery in adults with major depressive disorder.
This randomized clinical trial assesses the efficacy of mirtazapine for treatment of methamphetamine use disorder and reduction in HIV risk behaviors among cisgender men and transgender women.
This economic evaluation compares the use of brief cognitive behavioral therapy with the usual treatment given in suicidal US Army soldiers.
This systematic review and meta-analysis of 69 randomized clinical trials assesses long-term outcomes after cognitive behavioral therapy for anxiety disorders, posttraumatic stress disorder, and obsessive-compulsive disorder.
This cohort study compares income-specific trends in the incidence rates of first psychiatric hospital admissions and evaluates whether an income gradient exists in the incidence rates at all levels of household income among adults in Finland.
This population-based cohort study investigates the relative risk of adverse pregnancy and neonatal outcomes among Swedish women with eating disorders.
This systematic review and meta-analysis assesses the association of patient treatment preference with dropout and clinical outcomes in adult psychosocial mental health interventions.
This case-control study uses a genome-wide association study and mendelian randomization to ascertain whether polygenic risk scores for sleep traits are associated with individuals with bipolar disorder I or II vs control participants.
This advances in diagnosis, prognosis, and treatment review examines current evidence on the clinical validity of DSM-5 attenuated psychosis syndrome.
This study examines the prevalence of autoantibodies against neuronal surface antigens in the sera of individuals with psychotic disorders compared with control participants.
Create a personal account or sign in to: